May CPI and Housing...
Conglomerates: Conglomerates
Lydall Inc. (LDL: NYSE)
$14.60 0.32 | 2.24%
06/18/13 - 04:05 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 378.92M | 383.59M | 338.01M | 248.95M |
| Cost of Sales | 287.44M | 301.08M | 265.32M | 199.42M |
| Gross Operating Profit | 91.49M | 82.51M | 72.68M | 49.52M |
| Selling, General, and Administrative Expenses | 57.24M | 52.94M | 55.78M | 50.78M |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income before D & A (EBITDA) | 34.25M | 29.57M | 16.91M | -1.26M |
| Depreciation & Amortization | 13.68M | 15.00M | 14.81M | 16.06M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | -31.00K | 1.71M | 2.68M | 232.00K |
| Special Income / Charges | 810.00K | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 21.35M | 16.28M | 4.78M | -17.09M |
| Interest Expense | 365.00K | 880.00K | 854.00K | 814.00K |
| Pre-Tax Income | 20.98M | 15.40M | 3.93M | -17.90M |
| Income Taxes | 4.18M | 6.36M | 1.19M | -3.74M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 16.81M | 9.05M | 2.74M | -14.16M |
| Net Income From Discontinued Operations | 0.00 | 4.73M | 0.00 | 0.00 |
| Net Income From Total Operations | 16.81M | 13.78M | 2.74M | -14.16M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 16.81M | 13.78M | 2.74M | -14.16M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
16.00M | 9.05M | 2.74M | -14.16M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 16.81M | 9.05M | 2.74M | -14.16M |
| Basic EPS from Continuing Ops. | 1.01 | 0.54 | 0.16 | -0.85 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.28 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.01 | 0.82 | 0.16 | -0.85 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.01 | 0.82 | 0.16 | -0.85 |
| Basic Normalized Net Income/Share | 0.96 | 0.54 | 0.16 | -0.85 |
| EPS fr Continuing Ops. | 0.99 | 0.54 | 0.16 | -0.85 |
| EPS fr Discontinued Ops | 0.00 | 0.28 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.99 | 0.82 | 0.16 | -0.85 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.99 | 0.82 | 0.16 | -0.85 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.94 | 0.54 | 0.16 | -0.85 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with LDL
- Portfolio NameUser Type
- UserSUPRATRADE Top 10 Best-Perf...
- ContributorBarron's Activist Stocks 6-...
- UserJonock Portfolio 1
- UserRAPTOR SPRTD RED -0311081629
- Userjdlyall Portfolio 1
- UserNymph's Russell 2000 Rebala...
- UserBLACKTRADER116 Portfolio 1
- UserBENITRANS DP
- UserSUPRATRADE-QM PROJECT
- UserWealth Builder
Latest LDL Headlines from TheStreet
- Lydall To Attend The Sidoti & Company, LLC Semi-Annual NY Micro Cap Conference 05.23.13 | 10:05 am
- Lydall Names New Vice President And General Counsel 05.10.13 | 11:05 am
- Lydall Announces Financial Results For The First Quarter Ended March 31, 2013 And Expansion Into China 05.01.13 | 07:05 am
- Lydall First Quarter Ended March 31, 2013 Earnings Release And Conference Call Scheduled For May 1, 2013 04.25.13 | 04:04 pm
- Lydall Announces Financial Results For The Fourth Quarter And Year Ended December 31, 2012 02.26.13 | 07:02 am
- Charter Medical To Be The Exclusive Distributor For CELLution Biotech In North America And The European Union 02.22.13 | 08:02 am
- Lydall Fourth Quarter Ended December 31, 2012 Earnings Release And Conference Call Scheduled For February 26, 2013 02.21.13 | 04:02 pm
- Lydall To Attend The Sidoti & Company, LLC Annual New York Micro Cap Conference 01.04.13 | 01:01 pm
- Lydall Performance Materials Announces A Price Increase 10.15.12 | 04:10 pm
- Charter Medical Launches New EXP-Pak(TM) Cell Expansion Containers For Cellular Therapy Applications 10.09.12 | 10:10 am
Press Releases for LDL
- Investigation Of Lydall, Inc. By Securities Lawyers At Goldfarb Branham Law Firm LLP For Potential Shareholder Claims - PR Newswire 01.25.12 | 10:01 am
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By Lydall, Inc. - PR Newswire 11.21.11 | 05:11 pm
- Rigrodsky & Long, P.A. Announces Investigation Of Lydall, Inc. - Business Wire 11.17.11 | 12:11 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Lydall, Inc. - Business Wire 11.16.11 | 05:11 pm
Partner Headlines for LDL
- Lydall Inc - Aggressive Growth - Zacks 04.11.11 | 01:04 am
- Textron Opens Canadian Facility - Analyst Blog - Zacks 03.22.11 | 08:03 pm
